Meeting Banner
Abstract #3021

Non-Invasive Quantification of Anti-Angiogenic Therapy by Contrast Enhanced MRI in Experimental Pancreatic Cancer

Hans-Juergen Raatschen1, Christian Olaf Schoenfeld1, Birgit Hotz2, Hubert G. Hotz2

1Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany; 2General, Vascular and Thoracic Surgery, Charit Universittsmedizin Berlin, Berlin, Germany

Pharmacokinetic analysis of dynamic, albumin-(Gd-DTPA)-enhanced MRI appears to be a sensitive method to quantify angiogenesis-inhibiting effects of bevacizumab and suramin well before changes in tumor volumes can be detected and thus might be a useful addition to morphological MRI in the follow-up of antiangiogenic cancer treatment.

Abstract PDF

Keywords

addition administration albumin among anti appears assayed assessing cancer cancers compartment contrast control detected diagnostic dynamic early enhanced establish experimental fractional fragments general hours implanted inhibited inhibiting inhibition inhibitors initiated initiation invasive larger lewis materials measure medical might model monitoring morphological pancreatic permeability pillar pivotal plasma quantification quantify radiology rats reduced remained representative respectively response school sensitive significantly smaller suited surgery tail therapy thoracic treatment tumor tumors untreated useful vascular volumes week weeks